- Home
- ARWR vs AEIS Comparison
ARWR vs AEIS Comparison
Compare ARWR & AEIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | AEIS |
|---|---|---|
| Founded | 2003 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 11.3B |
| IPO Year | 2009 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ARWR | AEIS |
|---|---|---|
| Price | $67.09 | $261.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | $83.40 | ★ $307.73 |
| AVG Volume (30 Days) | ★ 1.6M | 473.0K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.11% |
| EPS Growth | 99.80 | ★ 168.53 |
| EPS | N/A | ★ 2.86 |
| Revenue | $16,142,321.00 | ★ $453,095,000.00 |
| Revenue This Year | N/A | $22.53 |
| Revenue Next Year | N/A | $13.38 |
| P/E Ratio | ★ N/A | $91.62 |
| Revenue Growth | N/A | ★ 38.39 |
| 52 Week Low | $31.46 | $163.39 |
| 52 Week High | $95.49 | $397.44 |
Technical Indicators
Market Signals| Indicator | ARWR | AEIS |
|---|---|---|
| Relative Strength Index (RSI) | 25.28 | 41.79 |
| Support Level | $60.60 | $248.91 |
| Resistance Level | $71.83 | $277.00 |
| Average True Range (ATR) | 4.01 | 10.30 |
| MACD | -2.24 | -1.38 |
| Stochastic Oscillator | 10.13 | 30.18 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About AEIS Advanced Energy Industries Inc.
Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.